This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Anscher MS et al. (1995) Adjuvant radiotherapy for pathologic stage T3/T4 adenocarcinoma of the prostate: ten-year update. Int J Radiat Oncol Biol Phys 33: 37–43
Pound CR et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591–1597
Swanson G et al. (2005) Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794) [Abstract]. Int J Radiat Oncol Biol Phys 63 (Suppl 1): S1
Feng M et al. (2005) Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy [Abstract]. Int J Radiat Oncol Biol Phys 63 (Suppl 1): S127
Acknowledgements
The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kuban, D. Does postoperative adjuvant radiotherapy reduce biochemical progression after radical prostatectomy?. Nat Rev Urol 3, 70–71 (2006). https://doi.org/10.1038/ncpuro0377
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0377